Quality control reagents and methods

US10908135B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10908135-B2
Application numberUS-201916549769-A
CountryUS
Kind codeB2
Filing dateAug 23, 2019
Priority dateFeb 13, 2013
Publication dateFeb 2, 2021
Grant dateFeb 2, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides reagents for instrumentation quality control and methods of use thereof. In particular, sets of peptides or other molecules are provided for evaluating the performance of instruments with mass spectrometry (MS) and/or liquid chromatography (LC) functionalities.

First claim

Opening claim text (preview).

The invention claimed is: 1. A peptide mixture comprising four or more distinct-mass versions of each of five or more distinct-sequence peptides, wherein three or more of the distinct-mass versions of each distinct-sequence peptide comprises one or more amino acids with above natural-abundance levels of one or more heavy isotopes, wherein the distinct-mass versions of each distinct-sequence peptide are present at distinct concentrations, and wherein the distinct-sequence peptides do not contain tryptophan, cysteine, or histidine residues or internal lysine or arginine residues. 2. The peptide mixture of claim 1 , wherein the peptides are present at concentrations ranging from 10 nM to to 1 μM. 3. The peptide mixture of claim 2 , wherein the peptides are present at concentrations ranging from 1 nM (femtomoles per microliter) to 10 μM. 4. The peptide mixture of claim 1 , wherein the distinct-sequence peptides are separable by liquid chromatography based on their different hydrophobicities. 5. The peptide mixture of claim 1 , wherein the distinct-sequence peptides are separable by liquid chromatography based on their different charge, size, or hydrophilicity. 6. The peptide mixture of claim 1 , comprising 5-10 distinct-sequence peptides. 7. The peptide mixture of claim 1 , wherein the distinct-mass versions of any of the distinct-sequence peptides are differentiable by mass spectrometry. 8. The peptide mixture of claim 1 , wherein the distinct-mass versions of any of the distinct-sequence peptides are the result of different combinations of stable heavy isotope-labeled amino acids. 9. The peptide mixture of claim 8 , wherein each of the distinct-mass versions of any of the distinct-sequence peptides comprises a different number of uniformly stable isotope-labeled amino acids. 10. The peptide mixture of claim 1 , comprising 5-10 distinct-mass versions of each of the distinct-sequence peptides. 11. The peptide mixture of claim 1 , wherein the distinct-sequence peptides do not contain proline residues. 12. The peptide mixture of claim 1 , wherein the distinct-sequence peptides do not contain glutamine residues. 13. The peptide mixture of claim 1 , wherein the distinct-sequence peptides do not contain asparagine residues. 14. The peptide mixture of claim 1 , wherein the distinct-sequence peptides do not contain terminal aspartate residues. 15. The peptide mixture of claim 1 , wherein the distinct-sequence peptides do not contain terminal glutamate residues.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10908135B2 cover?
The present invention provides reagents for instrumentation quality control and methods of use thereof. In particular, sets of peptides or other molecules are provided for evaluating the performance of instruments with mass spectrometry (MS) and/or liquid chromatography (LC) functionalities.
Who is the assignee on this patent?
Promega Corp
What technology area does this patent fall under?
Primary CPC classification G01N30/8665. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).